Xconomy’s Digital Events →
Photo courtesy of 480 Biomedical.
Sponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.